AID Life Science Holdings Limited provided earnings guidance for the year ended December 31, 2019. The company, one of the financial assets at fair value through profit or loss of the Group, has recorded losses of HKD 17.9 million. While the losses recognised on equity investment in China Creative was HKD 641.2 million during the year ended 31 December 2018, the losses in the investment has substantially decrease by approximately 97%.